pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,342 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: 8k filing×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Week of May 25, 2026

    17
    ›May 29, 20268k filing56d ago$ANAB — ANAPTYSBIO, INC (ANAB) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$BNTC — Benitec Biopharma Inc. (BNTC) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$EQ — Equillium, Inc. (EQ) — 8-K filing

    Items: 5.07, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$NMRA — Neumora Therapeutics, Inc. (NMRA) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$ACAD — ACADIA PHARMACEUTICALS INC (ACAD) — 8-K filing

    Items: 5.02, 5.07, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$LNSR — LENSAR, Inc. (LNSR) — 8-K filing

    Items: 5.02, 5.08, 8.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$PROK — PROKIDNEY CORP. (PROK) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$RANI — Rani Therapeutics Holdings, Inc. (RANI) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d agoSilexion Therapeutics Corp (SLXN, SLXNW) — 8-K filing

    Items: 3.03, 5.03, 8.01, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$SCYX — SCYNEXIS INC (SCYX) — 8-K filing

    Items: 5.03, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$EDSA — Edesa Biotech, Inc. (EDSA) — 8-K filing

    Items: 5.02, 5.07, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$APTOF — Aptose Biosciences Inc. (APTOF) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$LSTA — LISATA THERAPEUTICS, INC. (LSTA) — 8-K filing

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$OTLK — Outlook Therapeutics, Inc. (OTLK) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$VREOF — Vireo Growth Inc. (VREOF) — 8-K filing

    Items: 1.01, 2.03, 7.01, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$REPL — Replimune Group, Inc. (REPL) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›May 29, 20268k filing56d ago$EXEL — EXELIXIS, INC. (EXEL) — 8-K filing

    Items: 5.02, 5.07, 9.01

    full page →edgar 8k ↗

    Week of Jun 1, 2026

    33
    ›Jun 1, 20268k filing53d ago$LSTA — LISATA THERAPEUTICS, INC. (LSTA) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing
    ← prev
    page 23 of 47
    next →
    53d ago
    $MLTX — MoonLake Immunotherapeutics (MLTX) — 8-K filing

    Items: 1.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$NOTV — Inotiv, Inc. (NOTV) — 8-K filing

    Items: 1.01, 2.03, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$SMMT — Summit Therapeutics Inc. (SMMT) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d agoSkyAI, Inc. (STSS, STSSW) — 8-K filing

    Items: 5.03, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$HCWB — HCW Biologics Inc. (HCWB) — 8-K filing

    Items: 3.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$ELTP — ELITE PHARMACEUTICALS INC /NV/ (ELTP) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d agoJasper Therapeutics, Inc. (JSPR, JSPRW) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$RLYB — Rallybio Corp (RLYB) — 8-K filing

    Items: 1.01, 3.02, 5.01, 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$TFX — TELEFLEX INC (TFX) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$JBIO — Jade Biosciences, Inc. (JBIO) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$EIKN — Eikon Therapeutics, Inc. (EIKN) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$ELOX — Eloxx Pharmaceuticals, Inc. (ELOX) — 8-K filing

    Items: 3.02, 3.03, 5.02, 5.03, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$INAB — IN8BIO, INC. (INAB) — 8-K filing

    Items: 1.01, 1.02, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$CATX — Perspective Therapeutics, Inc. (CATX) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$NXTC — NextCure, Inc. (NXTC) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$VYGR — Voyager Therapeutics, Inc. (VYGR) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$LIXT — LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$SILO — Silo Pharma, Inc. (SILO) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$TTRX — Turn Therapeutics Inc. (TTRX) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$ADTX — Aditxt, Inc. (ADTX) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$EWTX — Edgewise Therapeutics, Inc. (EWTX) — 8-K filing

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$ONCY — ONCOLYTICS BIOTECH INC (ONCY) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$OTLK — Outlook Therapeutics, Inc. (OTLK) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$RNAZ — Transcode Therapeutics, Inc. (RNAZ) — 8-K filing

    Items: 5.08

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$CHRS — Coherus Oncology, Inc. (CHRS) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$RVRC — Revium Rx. (RVRC) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$IDYA — IDEAYA Biosciences, Inc. (IDYA) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$FULC — Fulcrum Therapeutics, Inc. (FULC) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$XCUR — EXICURE, INC. (XCUR) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$PRAX — Praxis Precision Medicines, Inc. (PRAX) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$KROS — Keros Therapeutics, Inc. (KROS) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 1, 20268k filing53d ago$SYRE — Spyre Therapeutics, Inc. (SYRE) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗